Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of lebrikizumab in volunteers.

Trial Profile

Phase I trial of lebrikizumab in volunteers.

Not stated
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2011

At a glance

  • Drugs Lebrikizumab (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Sponsors Tanox
  • Most Recent Events

    • 06 Sep 2011 Status changed from active, no longer recruiting to unconfirmed (it is not clear if Tanox completed this trial as the company was later acquired by Genentech).
    • 01 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top